Screener
Merit Medical Systems MMSI Single Reportable — Cost Depreciation Amortization And Depletion
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:CostDepreciationAmortizationAndDepletion.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Net sales | $381,877 | $355,351 |
| Cost of sales standard(1) | 147,017 | 142,803 |
| Cost of sales other(2) | 50,063 | 40,528 |
| Selling and marketing expenses | 73,957 | 64,929 |
| General and administrative expenses | 44,253 | 42,557 |
| Research and development expenses | 22,609 | 22,478 |
| Other operating expenses(3) | (179) | 1,023 |
| Other (income) expense — net | (9,389) | 3,075 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's single reportable — cost depreciation amortization and depletion?
- Merit Medical Systems (MMSI) reported single reportable — cost depreciation amortization and depletion of $50.06M in Q1 2026.
- What does single reportable — cost depreciation amortization and depletion mean?
- This metric represents the non-cash expenses allocated to the segment for the wear and tear of manufacturing equipment, facilities, and the amortization of intangible assets. It reflects the capital intensity required to maintain the segment's production capabilities and technological infrastructure. Investors use this to understand the impact of past capital investments on current segment profitability.
Ask your AI about Merit Medical Systems's single reportable — cost depreciation amortization and depletion.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude